Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer

Clinical trial NCT04596150 · COMPLETED

Trial details

NCT number: NCT04596150
Sponsor: CytomX Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms Breast Neoplasms Breast Neoplasms, Triple-Negative Breast Cancer Breast Neoplasms, Hormone Receptor Positive/HER2 Negative

Start date: 2020-12-29
Primary completion: 2023-06-02
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.